Onconetix, Inc. Annual Deferred Income Tax Expense (Benefit) in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Onconetix, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate for 2023.
  • Onconetix, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$122K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.6K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.